1226899-10-0 Usage
Chemical structure
Piperidinol derivative with a piperidine ring and an oxetane ring
Explanation
The compound is derived from piperidinol, which is a type of organic compound containing a six-membered nitrogen-containing ring called a piperidine ring. Additionally, it has an oxetane ring, which is a three-membered ring containing one oxygen atom.
3. Potential pharmacological properties
Explanation
The compound may have various biological activities and interactions with biological targets, making it a candidate for further research in the field of medicinal chemistry.
4. Applications in drug development
Explanation
Due to its unique structure and potential interactions with biological targets, 1-(oxetan-3-yl)piperidin-4-ol may be useful in the development of new drugs for various medical conditions.
Explanation
To fully understand the potential uses and effects of 1-(oxetan-3-yl)piperidin-4-ol, more research is required to investigate its pharmacological properties (how it interacts with biological targets) and toxicological properties (potential adverse effects on living organisms).
Further studies needed
Pharmacological and toxicological properties
Check Digit Verification of cas no
The CAS Registry Mumber 1226899-10-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,6,8,9 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1226899-10:
(9*1)+(8*2)+(7*2)+(6*6)+(5*8)+(4*9)+(3*9)+(2*1)+(1*0)=180
180 % 10 = 0
So 1226899-10-0 is a valid CAS Registry Number.
1226899-10-0Relevant articles and documents
SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4
-
Page/Page column 172; 190, (2020/02/16)
The present invention relates to novel quinazolinone derivatives of formula (I) as well as pharmaceutical compositions containing these compounds. The compounds of formula (I) as provided herein can act as positive allosteric modulators of metabotropic glutamate receptor subtype 4 (mGluR4), and can thus be used as therapeutic agents, particularly in the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions or conditions which can be affected by alteration of glutamate level or signalling.
4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS
-
Page/Page column 170, (2016/06/14)
The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
